Introduction
Despite ongoing efforts to reduce high-risk sexual behaviour and encourage the use of prophylactic devices, the incidence of HIV/AIDS is growing (Esparza and Bhamarapravati 2000) . In 2006, 39.5 million people were living with HIV/AIDS worldwide, 4.3 million people became newly infected with the disease, and a total of 2.6 million people had died of HIV/AIDS related causes. About 96% of cases are currently in sub-Saharan Africa (Esparza and Bhamarapravati 2000; Global Health Council 2006) . A total of 24.7 million people were living with HIV/AIDS, 2.8 million were newly infected individuals and there were 2.1 million deaths in sub-Saharan Africa for 2006 (UNA-IDS/WHO 2006).
At present, young people aged 15-24 account for half of all new HIV infections worldwide, with approximately 6,000 young people becoming infected with HIV every day (UNAIDS/WHO 2006). It appears that South African adolescents commence sexual activity at an early age (Buga et al. 1996) . Other studies have confirmed early sexual debut (Kuhn et al. 1994; Visser 1995) as well as multiple sexual partners among South African adolescents (Richter 1996 , cited in Hartell 2005 . It has been reported that low self-perceived susceptibility to HIV infection partly accounts for the high-risk sexual behaviour among South African adolescents (Galloway 1999; Kuhn et al. 1994) . In light of this, adolescents are a key target group, for both preventative efforts and HIV vaccine trials (Swartz et al. 2005) . The vaccination of adolescents before the start of sexual risk behaviour may therefore potentially be one of the most effective ways to control the HIV pandemic (McClure et al. 2004) , and should be prioritised among adolescents and preadolescents once a vaccine becomes available (Jaspan et al. 2006 ).
An effective, safe and affordable HIV preventative vaccine offers a promising long-term hope to control the global epidemic (Esparza and Bhamarapravati 2000) . Phase III HIV vaccine efficacy trials will require the recruitment and retention of many trial participants (O'Connell et al. 2002) . There is currently little empirical research evidence on willingness to participate (WTP) in HIV vaccine trials in developing countries, where HIV is most prevalent (Jaspan et al. 2006; Lindegger et al. 2007; Smit et al. 2006) , and the international research that does exist is not commonly informed by behavioural theory (Priddy et al. 2006 ). This study addresses both these gaps. A social cognitive model that has been shown to be empirically robust is the Theory of Planned Behaviour (TPB) developed by Ajzen (1988) . The TPB has been used to assess a variety of behaviours including health-related behaviours. To date, no studies have used the TPB to predict participation in vaccine or other clinical trials. There is, indeed, good reason to be sceptical concerning the extent to which the TPB may be used to explain a construct such as WTP. Kafaar et al. (2007) address the question of whether or not participation in an HIV vaccine trial can be regarded as a health behaviour. Participation in an HIV vaccine trial may provide no direct health benefits to participants as it is not known whether or not the vaccine being tested is effective or not. The authors argue that from the perspective of a participant, however, receiving an HIV vaccine in the context of a trial may increase the likelihood of protection from HIV infection above that of an individual who does not receive the candidate vaccine (Kafaar et al. 2007 ). In addition, participation in such trials and regular visits to trial site clinics reminds individuals repeatedly of their risk for HIV infection (Kafaar et al. 2007) . Such reminders may encourage behaviours that decrease the likelihood of HIV infection. In this sense it may be appropriate to apply existing theories of health behaviour in order to gain an understanding of WTP. On the other hand, trial investigators may consider it inappropriate to regard participation in an HIV vaccine trial as a health behaviour as none, or not all the participants may directly benefit from HIV vaccine trial participation (Kafaar et al. 2007) .
With no Phase III vaccine trials currently or imminently underway-in South Africa, WTP as a construct is necessarily hypothetical in nature. In the present study, therefore, no specific behaviour was tested using the TPB. The intentional component of the TPB was considered a proxy for WTP. As stated by Albarracín et al. (2001) an individual's overt behaviour is determined by his or her intention/or willingness to perform the specific behaviour. Previous research has therefore regarded the intention to perform a behaviour and willingness to perform behaviour as synonymous constructs. In the present study we were interested in whether a person's level of WTP in an HIV vaccine trial was influenced by three determinants, namely: attitude towards participation in an HIV vaccine trial, the perceived social pressure to participate or not participate in an HIV vaccine trial and, self-efficacy with respect to participation in an HIV vaccine trial, despite difficult circumstances. In addition to the TPB variables, four additional variables were included, namely, perceived risk of HIV infection, knowledge of HIV vaccine trials, attitudes towards HIV and AIDS, and health-promoting behaviours.
There is evidence that perceived risk of HIV infection is significantly related to WTP in an HIV vaccine trial among various samples internationally (Jenkins et al. 2000; Johnson 2000; Kiwanuka et al. 2004; McGrath et al. 2001a, b; Newman et al. 2006; O'Connell et al. 2002; Périssé et al. 2000; Sahay et al. 2005; Sherr et al. 2004; Starace et al. 2006) . Among a South African sample of 16-40 year old participants, self-perceived HIV risk was significantly associated with WTP (Smit et al. 2006 ). Although numerous studies have reported a significant relationship between perceived HIV risk and WTP in specific samples, there is a paucity of research focusing on this relationship among South Africans.
Considerable research has assessed knowledge of HIV vaccines and HIV vaccine trial methodology among specific samples (MacQueen et al. 1999; McGrath et al. 2001a, b; Strauss et al. 2001) . Other studies have investigated the association between knowledge of HIV vaccines and WTP among various samples (Halpern et al. 2001; Kiwanuka et al. 2004; Koblin et al. 2000; O'Connell et al. 2002; Priddy et al. 2006; Sahay et al. 2005; Smit et al. 2006; Starace et al. 2006) . In South Africa, there is generally a low level of knowledge of HIV vaccine trials and what enrolment in these trials entails (Smit et al. 2006 ). This lack of understanding and knowledge of HIV vaccine trials, and the paucity of research assessing the association between this construct and WTP among adolescents, indicates a need to further investigate knowledge levels among South African adolescents, and to determine the relationship, if any, between this construct and WTP.
Negative social responses to the HIV epidemic remain pervasive, even in those communities seriously affected by HIV/AIDS (Parker and Aggleton 2003) . These negative social responses to HIV/AIDS impede efforts aimed at promoting voluntary counselling and testing and other HIV/AIDS prevention efforts (Kalichman and Simbayi 2004) . According to Kalichman and Simbayi (2004) HIV and AIDS-related stigma is pervasive in South African communities. There is however a lack of research focusing on adolescent attitudes toward HIV/AIDS in South Africa. Moreover, a review of the literature revealed no research directly focusing on the association between attitudes toward HIV/AIDS and WTP in an HIV vaccine trial among adolescents. There is however evidence that negative attitudes toward HIV/AIDS persist in South Africa and that these attitudes have been cited as an inhibitor to HIV vaccine trial participation (Lesch et al. 2006) . The relationship AIDS Behav (2008) 12:842-851 843 between attitudes toward HIV/AIDS and WTP among South African adolescents awaits investigation. To our knowledge there is no research that explicitly describes and predicts the relationship between healthpromoting behaviours and WTP among adolescents. Prior research has focused on the relationship between health behaviours and the acceptance of a hypothetical HIV preventative vaccine (Liau and Zimet 2000; Zimet et al. 1999) and the relationship between health behaviours and WTP in HIV preventative intervention programs (Yang et al. 2004) . The question of whether or not health-promoting behaviours are predictive of WTP similarly requires examination.
The aim of the present study was to determine whether the TPB could predict WTP among South African adolescents. In addition, we sought to determine whether the additional variables of Perceived self-risk of HIV infection, Knowledge of HIV vaccines and HIV vaccine trials, Attitudes towards HIV/AIDS and Health-promoting behaviours could further explain the WTP construct.
Method

Participants
A convenience sample of 224 grade 10 and 11 learners attending two secondary schools located in a peri-urban township in the Western Cape Province, South Africa was recruited for the present study. The township was established as a result of the migrant labour system and is one of the oldest and fastest developing townships in South Africa. Community members are predominantly black and Xhosa-speaking. The township is home to approximately 325,000 people and the average monthly income is approximately R1126 (roughly US$160) (Busgeeth and Rivett 2004) .
Procedure
Permission to conduct the research in the relevant secondary schools was obtained from the Western Cape Education Department and the principals of the schools where the data were collected. Ethical clearance to conduct the relevant study was obtained from the Internal Review Board at Stellenbosch University. The battery of questionnaires was translated into Xhosa and administered in English and Xhosa, according to participants' preferences. Two fieldworkers collected the data at the schools in the school halls and in classrooms. The fieldworkers were introduced to the participants and carefully explained the study to them. The participants were assured of confidentiality and anonymity and were asked to provide written informed consent. Subsequently, the researcher presented a brief pre-test workshop in which HIV vaccines and HIV vaccine trials were explained to the participants. Although no measures were taken to correct misinformation regarding HIV vaccines after the data were collected, the pre-test workshop did impart vital information, for example, the fact that the HIV vaccine is preventive, that the vaccine may offer little or no protection from HIV and that no HIV vaccine currently exists. The participants then completed the battery of instruments and received a small token of appreciation for their participation in the present study.
Measures
Demographic Information
Gender, age, grade and ethnicity were assessed using a self-administered questionnaire.
Perceived Risk of HIV Infection
To measure participants' perceived self-risk of HIV infection, we developed a Visual Analogue Scale (VAS). The VAS was a 12 cm horizontal line anchored by descriptive words on each end of the line. The participants were asked to indicate with a cross on the continuum ranging from ''very low risk'' (0 cm) to ''very high risk'' (12 cm), how much at risk they thought they were of contracting HIV. Higher scores indicated a higher perceived self risk of HIV infection.
Willingness to Participate (WTP) in an HIV Vaccine Trial
To measure participants' WTP in a future Phase III HIV vaccine trial, a second VAS was constructed. The participants were asked to indicate with a cross on the continuum ranging from ''very unwilling to participate'' (0 cm) to ''very willing to participate'' (12 cm), how willing they were to participate in a hypothetical Phase III HIV vaccine trial. Higher scores indicated a greater WTP.
Knowledge of HIV Vaccines and HIV Vaccine Trials
In order to measure participants' knowledge of HIV vaccines, HIV vaccine trials and related concepts, we developed an instrument consisting of 23 items (with a true-false response option). Examples of items that appeared in the instrument are: ''a placebo is a fake treatment that is similar to the real vaccine or drug''; ''HIV vaccines are given to help prevent someone from becoming infected with HIV''; and ''if you enrol in an HIV vaccine trial you will get the appropriate medication, medical tests, and HIV tests regularly all the way through the trial''. The instrument was scored by giving a one for a correct response and a zero for an incorrect response. Thus, a minimum total score of zero and a maximum total score of 23 was possible. Higher scores indicated an increased knowledge about HIV vaccines, HIV vaccine trials and related concepts. The research team extensively reviewed and refined the newly constructed instrument before it was administered. Internal consistency as measured by Cronbach's a was 0.77 among the sample.
Attitudes Towards HIV/AIDS
To measure participants' attitude towards HIV/AIDS, the AIDS-related Stigma Scale developed by Kalichman et al. (2005) was used. The original scale consisted of nine items (with a two-option response format consisting of ''I agree'' and ''I disagree''). However, for the present study, this twooption response format was changed to a four-option Likert response format ranging from ''strongly disagree'' to ''strongly agree'' in order to achieve continuity in participant responses. Positively worded items such as ''it is safe for people with AIDS to work with children'' were scored from 1 (strongly disagree) to 4 (strongly agree). Negatively worded items such as ''people who have AIDS are dirty'' were reverse scored from 4 (strongly agree) to 1 (strongly disagree). Higher scores indicated a more positive participant attitude towards HIV/AIDS. In order to ensure that the scale not only measured AIDS stigma but also measured positive attitudes towards HIV/AIDS, item number 7 ''people who have AIDS should be isolated'' was changed to ''people who have AIDS should not be isolated'' and item number 9 ''people who have AIDS should not be allowed to work'' was changed to ''people who have AIDS should be allowed to work''.
In five South African communities the original scale was found to be internally consistent (a = 0.75), with Cronbach's a ranging from 0.64 to 0.83 across the samples (Kalichman et al. 2005) . These samples consisted of a total of 2,306 participants over the age of 18 years. The scale was found to be stable over time, both at 1 month (r = 0.68, P < 0.01) and 3 months (r = 0.67, P < 0.01). Moreover, the scale has internal consistency in English (a = 0.78), Xhosa (a = 0.88) and Afrikaans (a = 0.71) (Kalichman et al. 2005) . Before the scale was used, the research team reviewed the changes made. In the present study, the Cronbach a reliability coefficient was 0.60.
Health-Promoting Behaviours
To measure participants' health-promoting behaviours, the Health-Promoting Lifestyle Profile (HPLP) developed by Walker et al. (1987) was used. However, in order to avoid response fatigue, the original instrument, which consisted of 48 items, was shortened into a 15 item instrument by selecting items with the highest factor loading on each subscale reported by Walker et al. (1987) . Participants were asked to indicate how frequently they performed each health-promoting behaviour: ''Never'', ''Sometimes'', ''Often'' and ''Routinely''. Higher scores indicated more frequent performance of the healthy lifestyle behaviours. The a reliability coefficients for each sub-scale reported by Walker et al. (1987) are as follows: Self-actualisation: 0.90; Health responsibility: 0.81; Exercise: 0.81; Nutrition: 0.76; Interpersonal support: 0.80 and Stress Management: 0.70 while for the total scale it was 0.92. Test-retest reliability was 0.93 for the total scale and ranged from 0.81 to 0.91 for the subscales (Walker et al. 1987 ) over a 2-week period. In the present study, the a coefficient for the shortened scale was 0.70.
Attitude Towards Participation in an HIV Vaccine Trial
Using questionnaire guidelines provided by Francis et al. (2004) , we constructed a questionnaire with nine items to assess attitudes towards vaccine trial participation. Examples of items that appeared in the questionnaire are: ''participating in an HIV vaccine trial is: worthwhile/ worthless''; harmful/beneficial''; and pleasant/unpleasant''. Items with negative endpoints were reverse coded, so that higher scores reflected a more positive attitude toward participating in an HIV vaccine trial. A panel of experts in the Socio-behavioural working group of the South African AIDS Vaccine Initiative reviewed the newly constructed instrument before it was used. The a coefficient was 0.75 in the present study.
Subjective Norms
We followed a similar procedure for subjective norms, which resulted in a 6-item Likert-type questionnaire with four response options ranging from ''strongly disagree'' to ''strongly agree''. Examples of items are ''most people who are important to me think that I should participate in an HIV vaccine trial''; ''it is expected of me to participate in an HIV vaccine trial''; and ''approval of my participation in an HIV vaccine trial is important to me''. Higher scores indicated that participants thought that participation in an HIV vaccine trial was the norm while lower scores indicated that they thought it was not. The a coefficient for the present study was 0.75.
Perceived Behavioural Control
We again used the same procedures to construct a scale to measure perceived behavioural controls. The scale consisted of seven items such as ''I am confident that I could AIDS Behav (2008) 12:842-851 845 participate in an HIV vaccine trial if I wanted to''; ''the decision to participate in an HIV vaccine trial is beyond my control''; and ''whether or not I decide to participate in an HIV vaccine trial is entirely up to me''. Higher scores indicated a stronger perception of behavioural control over participation in an HIV vaccine trial. In the present study, a reliability coefficient was 0.66.
Analysis
The data were entered into SPSS. The variables, Perceived self-risk of HIV infection, Knowledge, Attitudes toward HIV/AIDS, Health-promoting behaviours, Attitudes, Subjective norms and Perceived behavioural control were entered into a multiple logistic regression analysis as predictors of importance, with WTP as the criterion variable. Two regression models were fitted. The first was a hierarchical logistic regression model with the TPB entered separately as a block and the additional remaining predictor variables entered in a second separate block. The second regression model was a forward stepwise method with all the predictor variables entered simultaneously into the model.
Results
Description of the Sample
A total of 224 adolescents attending two secondary schools located in an African Township on the Cape Flats completed questionnaires for the present study. Of the total sample, 42.9% were 10th-grade learners and 56.7% were 11th-grade learners. The participants were, on average, 17 years of age (M = 17.3, SD = 1.5). The age of the participants ranged from 14 to 21 years of age. All the participants were Black and there were more females (60.3%) than males (34.8%).
Regression Model 1: Hierarchical Logistic Regression Analysis
Of the total sample, 194 questionnaires were included in the analyses due to missing data. Following the guideline suggested by Field (2000) , a 15:1 subject to predictor ratio is sufficient for adequate statistical power to support multiple regression analyses. The Variance Inflation Factor (VIF) statistic indicated that collinearity was not a concern. However, the Kolmogorov-Smirnov test of normality indicated that the dependent variable did not conform to the normal curve. Consequently, we dichotomised the continuous dependent variable in order to permit logistic regression analyses. Participant scores for WTP ranged from 0 cm to 12 cm on the self-administered visual analogue scale. However, as there were no participant scores ranging from 6 cm to 8 cm for this variable, the cut-off point was made at a score of 8 cm on the visual analogue scale. Thus, WTP was dichotomised into those unwilling to participate in a future Phase III HIV vaccine trial (a score below 8 cm) and those willing to participate in a future Phase III HIV vaccine trial (a score above 8 cm). The Hosmer and Lemeshow, Cox and Snell R 2 , and Nagelkerke R 2 test statistics were non-significant (P > 0.05) for both steps one and two of the analysis, suggesting that the model was a good fit of the data. Table 1 shows the summary statistics for the hierarchical logistic regression analysis in which the predictive ability of the TPB (attitudes, subjective norms and perceived behavioural control), perceived self-risk of HIV infection, knowledge, attitudes towards HIV/AIDS and health-promoting behaviours was examined. The combination of the TPB variables significantly improved the prediction of WTP v 2 (3, N = 194) = 13.58, P < 0.01) with 79.9% prediction success. Only Subjective norms significantly predicted WTP, v 2 (1, N = 194) = 8.52, P < 0.01. The odds ratio indicated that as the perception of HIV vaccine trial participation being normative increased by one unit of measurement, the odds of WTP also increased, although negligibly (OR = 1.19, 95% C.I. = 1.06-1.34). None of the additional predictor variables further explained WTP among this sample. Therefore, in this regression model, the TPB alone robustly explained WTP.
Regression Model 2: Forward Stepwise Logistic Regression Analysis
The second regression model was exploratory. We used a forward stepwise method in which all the predictor variables were entered simultaneously into the model. The Hosmer and Lemeshow, and Nagelkerke R 2 test statistics were non-significant (P > 0.05) at both steps one and two of the analysis, again suggesting that the model was a good fit of the data. Table 2 shows the summary statistics for the forward stepwise logistic regression analysis in which the predictive ability of all the variables was investigated. In the first step, Subjective norms significantly predicted WTP (v 2 = 9.26, P < 0.01) and was added to the model first. The v 2 test of the full model with subjective norms was statistically significant, indicating that the inclusion of this variable significantly improved the prediction of WTP. Prediction success was high, at 78.4%. In the second step, Attitudes towards participation was added. The v 2 test of the step with the inclusion of the additional predictor was significant, indicating that Attitudes further explained WTP. Prediction success showed that an additional 2% of cases were classified after the inclusion of Attitudes, with a total of 80.4% of cases correctly classified by the model. Thus, both Subjective norms [v 2 (1, N = 194) = 9.81, P < 0.01; OR = 1.19, 95% C.I. = 1.07-1.34] and Attitudes [v 2 = 3.88, P = 0.05; OR = 1.32, 95% C.I. = 1.00-1.74] significantly predicted WTP.
Discussion
The purpose of the present study was to investigate the utility of the TPB in predicting and explaining the multifaceted nature of WTP among adolescents living in the Western Cape of South Africa. The present study found support for an earlier version of the TPB, namely, the Theory of Reasoned Action (TRA) (Ajzen and Fishbein 1980) , and suggests that psychosocial factors may influence adolescents' WTP.
Although no research has tested the ability of the TPB to predict WTP, there is some evidence that among South African communities, subjective norms may influence WTP (Lesch et al. 2006) . Therefore, an individual's perception of the social pressure placed on him or her by salient individuals with regard to participation may have a significant impact on enrolment in future HIV vaccine trials. Adolescents typically evaluate themselves and their own actions in the context of their peer group and are concerned about peer group acceptance in order to be popular, loved and respected by peers their own age (Kaplan 2000) . In light of this, it is likely that if trial participation is a perceived group norm, it may influence adolescents' decisions about future vaccine trial enrolment. Similarly, there is some evidence that attitudes may influence this construct (Allen et al. 2001; Lesch et al. 2006) . The risk of being stigmatised and discriminated against as a result of participation may influence potential participants' decision to enrol in such trials. In light of these findings, possible future interventions, such as HIV vaccine preparedness programs may aim to promote positive group norms and positive attitudes towards participation in an HIV vaccine trial among adolescents. A possible explanation for the support of the TRA and not the TPB as originally hypothesised is that measuring perceived behavioural control in this instance might have been unrealistic. Perceived behavioural control is influenced by an individual's beliefs about resources and opportunities available to perform the target behaviour, which may be based on past experience with the behaviour. These beliefs may also be influenced by information from external sources regarding the behaviour, and by observing the experiences of others regarding the behaviour (Ajzen 1988 ). The present study did not aim to recruit participants for an HIV vaccine trial, but aimed to merely assess hypothetical WTP. As hypothetical WTP is not equivalent to actual WTP (Buchbinder et al. 2004 ), issues of control over trial participation may not have been among these adolescents' primary concerns. Similarly, issues of control over trial participation may be influenced by the lack of information about, and unfamiliarity with HIV vaccine trials in South Africa (Smit et al. 2006) . Because Phase III HIV vaccine trials have not commenced in South Africa, participants had no reliable sources, information or experiences on which to base their control beliefs. Lastly, the majority of adolescents are still dependent on adults. As suggested by Swartz et al. (2005) , there are constraints on the power and autonomy possessed by adolescents. The freedom to be in control of the behaviour in question is not likely to be determined by an adolescent but by those adults on whom they are dependent. Considering the hypothetical nature of the study, the extent to which issues of control may be salient among individuals in the context of an actual behaviour requires further investigation.
In summary then, the data suggest that the combination of the two TRA variables were successful in predicting hypothetical WTP in an HIV vaccine trial among this sample of adolescents. These findings therefore support the utility of the TRA in predicting WTP in future HIV vaccine trials among adolescents. The process of testing theoretical models may aid the development of a robust theory to explain the multifaceted construct of WTP. We found that in both the first and the second regression models the additional variables, Perceived self-risk of HIV infection, Knowledge, Attitudes towards HIV/AIDS and Healthpromoting behaviours could not further predict and explain WTP.
Although Perceived self-risk of HIV infection has been identified as a significant predictor of WTP in several studies internationally, these findings may not be generalisable to South African adolescents. Similarly, although Smit et al. (2006) reported a significant relationship between this construct and WTP among a sample of 16-40 year old South Africans, the sample used in Smit et al's study was small and consisted of participants who had already volunteered to be part of a longitudinal HIV-related study. Therefore, their findings may not be generalisable to the entire community. The results of the present study indicate that among adolescents in the Western Cape, selfperceived susceptibility to HIV infection may not influence WTP. This finding warrants further investigation among other South African samples.
Although prior research has provided evidence for a significant relationship between knowledge of HIV vaccines and WTP, this construct did not significantly predict WTP among adolescents in the present study. This finding is in keeping with those of Halpern et al. (2001) and Priddy et al. (2006) who found no relationship between knowledge and WTP. Although logistic regression has no assumptions about the normality of predictor variables, the distribution of knowledge scores was significantly negatively skewed, indicating a greater number of scores on the right of the distribution. Consequently, there was limited variance in knowledge scores and this may have resulted in poor external validity, further contributing to null findings.
We found no significant relationship between Attitudes toward HIV/AIDS and WTP among the sample. A possible reason for this null finding is that the AIDS-related Stigma Scale (Kalichman et al. 2005) used in the present study may not have been optimally reliable among adolescents. The internal consistency of the scale in the present study was a = 0.60. The guidelines offered by Nunally (1978) suggest that a reliability of 0.70 or higher is acceptable for scales used in survey research. However, guidelines offered by Huysamen (1996 , cited in Wolfaardt 2001 suggest that a reliability coefficient of 0.65 or higher is acceptable for decisions about groups.
Finally, no prior research has investigated the relationship between health-promoting behaviours and WTP. Our findings showed no significant relationship between these variables. Thus, Health-promoting behaviours may indeed not influence adolescents' WTP. Given the lack of prior research, the relationship between health-promoting behaviours and WTP in an HIV vaccine trial awaits further investigation.
The findings of the study suggest that psychosocial determinants may influence adolescent decision-making regarding participation in a future Phase III HIV vaccine trial. HIV vaccine preparedness programs targeting adolescents should aim to influence group norms positively, increase normative pressure, and motivate adolescents to comply with this normative pressure to participate in an HIV vaccine trial. Additionally, HIV vaccine preparedness programs should aim to promote positive attitudes toward participation in a future Phase III HIV vaccine trial among adolescents. Positive group norms and positive attitudes toward participation in an HIV vaccine trial may promote participation in a future Phase III HIV vaccine trial among young adults.
On the other hand, a number of challenges are raised when considering adolescent participation in HIV vaccine trials (Jaspan et al. 2006; Lindegger et al. 2006; McClure et al. 2004; Strode et al. 2005; Swartz et al. 2005) . These challenges include, amongst others: (a) adolescents' ability to make informed decisions regarding a potentially harmful experimental vaccine; (b) the limited power and autonomy possessed by adolescents, and the rights of adults to make decisions on behalf of adolescents; (c) commitment to a long-term clinical trial; (d) the long-term implications of this commitment; and finally (e) that adolescent enrolment may be viewed as a risk behaviour in itself, due to a sense of being untouchable and having low perceptions of risk of HIV infection (Swartz et al. 2005) . However, as the incidence of HIV shows no sign of declining among adolescents, the inclusion of this age group in future HIV vaccine trials is widely considered to be necessary and important (McClure et al. 2004) . It may therefore be useful to learn from other preventive work conducted with adolescents (Swartz et al. 2005) , and to pay attention to the specific needs of recruitment, retention, and informed consent when dealing with adolescents (McClure et al. 2004) .
Limitations
Contrary to the evidence that South Africans have low knowledge of HIV vaccines and limited scientific literacy to understand HIV vaccine trial methodology (Smit et al. 2006) , the participants in the present study showed high knowledge scores. Before participants completed the battery of instruments, a short pre-test workshop was presented in which the HIV vaccine and the HIV vaccine trial methodology was presented and explained to participants. Consequently, the high knowledge levels in this sample may be an indication of participants' recall of the information presented to them regarding the HIV vaccine and HIV vaccine trial, rather than a true indication of knowledge levels. As there was limited space and insufficient desks at the schools, some participants sat close to each other during the test administration, which may have also increased the likelihood of sharing answers. Moreover, the TPB could not be tested in its entirety in the present study, due to the omission of a behavioural outcome. The study did not include a specific behavioural outcome beyond WTP, which was hypothetical in nature, and may therefore have limited the model's predictive ability. This variable was assessed using only one item, which may have been a further limitation of the study.
Despite these limitations, we found preliminary support for the use of the TRA in explaining hypothetical WTP among adolescents. Further application of this theory may be of substantial use in understanding adolescent WTP in future HIV vaccine trials.
